The annual meeting of the European Society of Cardiology (ESC), this year organised in Munich, had again a lot to offer to the interventional cardiologist. Important new data were presented on important topics such as: real life safety of the first generation drug eluting stents, new stent technology and the timing of adjunctive antithrombotic therapy in conjunction with primary PCI. Long awaited data was also released on large scale randomised trials comparing contemporary percutaneous (PCI) and surgical (CABG) revascularisation.
The main session on DES safety “Two years after Barcelona” stressed the importance of large scale registries because these reflect ...
Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue
(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))
December 6, 2019